North America Cardiovascular Ultrasound Market 2022-2028

North America Cardiovascular Ultrasound Market 2022-2028

MARKET OUTLOOK

According to the report by Triton Market Research, North America’s cardiovascular ultrasound market is likely to develop with a CAGR of 5.38% in the projected duration between 2022 and 2028. The United States and Canada are analyzed in the market in this region.

Earlier, hospital admissions for cardiovascular diseases in Canada were significantly lesser. However, in recent years, hospitalizations for these ailments have risen significantly. Hospitalization rates for structural heart disease stood at 50%, and for heart failure stood at 35%. Thus, there has been a significant demand for efficient cardiovascular ultrasound systems to diagnose these illnesses in the earlier stages. As a result, leading manufacturers are launching novel, technologically advanced products, which is expected to consolidate the market’s growth.

Heart diseases are a leading cause of death in the United States. Every year, close to 655,000 people in the country lose their lives to these ailments. Coronary heart disease (CHD) is the most common type of heart disease, which leads to nearly 366,000 deaths each year. Estimates suggest that 7.8% of adults in New York State reported having a heart attack, CHD, or stroke, in 2018. These diseases are more common among the elderly. In the same year, 1 in every 5 New Yorkers aged 65 years or older (20%) reported being affected by some form of heart disease. The alarming prevalence of these conditions has accelerated the demand for cardiovascular ultrasound systems, which is expected to foster the market’s growth.

COMPETITIVE OUTLOOK

Leltek Inc, Telemed Ultrasound Medical Systems, Zoncare, Fujifilm Holdings Corporation, Clarius, Samsung Medison Co Ltd, Siemens Healthineers, and Esaote S.p.A. are some of the noteworthy players operating in the cardiovascular ultrasound market.